Yang, L.,
Luo, W.,
Zhang, Q,
Hong, S.,
Wang, Y.,
Samorodov, A.V.,
Chattipakorn, N.,
Pavlov, V.N.,
Liang, G. (2021) , our data show that CAR treatment inhibited LPS-induced
lung damage, systemic inflammatory cytokine
Sufianov, Albert,
Begliarzade, Sema,
Beilerli, Aferin,
Liang, Yanchao,
Ilyasova, Tatiana,
Beylerli, Ozal (2023) Lung cancer is the leading cause of death and morbidity from malignant neoplasms worldwide, and its
Tyurin, Anton V.,
Akhiyarova, Karina E.,
Valishin, Damir A.,
Sadretdinova, Lidiya D.,
Khusainova, Leonora N.,
Zagidullin, Naufal S.,
Gantseva, Khalida K.,
Pavlov, Valentin N. (2022) of
lung damage in all groups, compared with the baseline level. Conclusion — Tocilizumab in the form
Sufianova, Galina,
Sufianova, Galina,
Beylerli, Ozal,
Wu, Jianing,
Shumadalova, Alina,
Sufianov, Albert,
Chen, Xin,
Zhao, Shiguang (2022) -inflammatory effects. Polyphenols help fight cell
damage caused by free radicals and immune system components
Gilyazova, Irina,
Gimalova, Galiya,
Nizamova, Aigul,
Nizamova, Aigul,
Ishbulatova, Ekaterina,
Pavlov, Valentin,
Khusnutdinova, Elza (2024) For several decades, most
lung cancer investigations have focused on the search for mutations